Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-342-7 | CAS number: 1163775-81-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 30th of July 2015 - 7th of September 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- 1,2,4-Benzenetricarboxylic acid, mixed dodecyl and octy triesters
- IUPAC Name:
- 1,2,4-Benzenetricarboxylic acid, mixed dodecyl and octy triesters
- Reference substance name:
- tris(mixed dodecyl and octyl)benzene-1,2,4-tricarboxylate
- EC Number:
- 700-342-7
- Cas Number:
- 1163775-81-2
- Molecular formula:
- C14H47O6 to C18H55O6
- IUPAC Name:
- tris(mixed dodecyl and octyl)benzene-1,2,4-tricarboxylate
- Reference substance name:
- Linplast 812 TM
- IUPAC Name:
- Linplast 812 TM
Constituent 1
Constituent 2
Constituent 3
- Specific details on test material used for the study:
- N/A
Test animals
- Species:
- mouse
- Strain:
- ICR
- Details on species / strain selection:
- N/A
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Beijing Vital River Laboratory animal technology Co., Ltd.
- Initial age at start of acclimatisation: 49-62 days
- Age at start of treatment: 55-68 days
- Weight at study initiation: 29.95-34.61 g (males)
- Assigned to test groups randomly: yes
- Fasting period before study: not mentioned
- Housing: 1 animal per cage (plastic cages (L29.0×W18.0×H16.0cm) lied on shelf (L167.0×W70.0×H171.0cm) in the SPF grade barrier system (room D124). There were 7 cages per layer, and 5 layers per rack)
- Bedding: Corn cob bedding was supplied by Beijing Keao Xieli Feed Co., Ltd. (Batch No.: 15049811)
- Diet (e.g. ad libitum): ad libitum (SPF rodent growth and breeding feed bought from Beijing Keao Xieli Feed Co., Ltd (Product License No: SCXK (jing) 2012-0001, Batch No. was 15033113)
- Water (e.g. ad libitum): ad libitum (drinking water, purified by HT-R01000 purity system)
- Acclimation period: adequate duration, not specified
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.8-24.4
- Humidity (%): 54 - 70
- Air changes (per hr): 17
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Justification for choice of solvent/vehicle: relatively non-toxic to the animals, result of solubility test
- Amount of vehicle: 0.2 mL/10 g bw
- Lot/batch no. (if required): MKBF8603V - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
4.000g/4.000g (the first administration/ the second administration) of the test item were weighed using the electronic balance and mixed with vehicle to the certain volume (40mL) as the concentration of 100mg/ml, then the suspension were continuously mixed round with homogenate machine for one minute at least. The test suspension of other concentrations were prepared by dilution by factor 2.
All test suspensions were prepared just before on the day of each administration. When prepared, the test item was weighed accurately and mixed with the vehicle thoroughly, in addition, the test item was applied to the test system within two hours after being formulated. It is assumed that the formulation was prepared exactly, homogeneously and was stable during the test. So no analysis was carried out to determine the homogeneity, concentration and stability of the test item formulation.
The order of administration was 0, 500mg/kg, 1000mg/kg, 2000mg/kg and CP (cyclophosphamide monohydrate = positive control) group. The accuracy of injector used was 0.02mL and the max volume was 1mL. Dosing formulations and vehicle were stirred on the magnetic stirrer at least 5 minutes prior to dosing and continuously stirred during dosing. At the first administration, academic dosing volume was calculated based on the body weight as grouping, and the corresponding volume based on the accuracy of injector was dosed to the animal. At the last administration, animals were weighed firstly, then academic volume was calculated and corresponding volume based on the accuracy of injector was dosed to the animal. All data during the treatment were recorded accurately. - Duration of treatment / exposure:
- N/A
- Frequency of treatment:
- twice with the test item with an interval approximately 24 hours
- Post exposure period:
- none
Doses / concentrationsopen allclose all
- Dose / conc.:
- 2 000 mg/kg bw/day (nominal)
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- Dose / conc.:
- 500 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 7 (6 (3 males and 3 females) in pre-experiment)
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide monohydrate (CP)
- Justification for choice of positive control(s): not mentioned
- Supplier: Sigma-Aldrich
- Batch no.: SLBG4216V
- Doses / concentrations: 50 mg/kg bw, single dose (2.5 mg/mL)
In this test, cyclophosphamide monohydrate (CP) was used as positive control item at the dose level of 50mg/kg (the concentration was 2.5mg/mL). 0.025g of CP was weighed and prepared in 10mL water as the positive control solution. The CP solution was prepared on the day of each treatment.
Examinations
- Tissues and cell types examined:
- N/A
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
Prior to the start of this study, a preliminary test had been performed to determine the maximum tolerated dose (MTD) in this lab. The test item came from the same supplier (Batch No.: 04698/MA; Content:>98%). Based on the result of the preliminary test, if the test item did not produce toxicity at 2000 mg/kg/body weight/day, the highest dose for an administration period should be 2000 mg/kg/body weight/day in this micronucleus test. However, if the test item does cause toxicity, the maximum tolerated dose (MTD) should be the highest dose administered in this micronucleus test.
In the preliminary test, the same species animals with the micronucleus test were used. Before administration, based on the result of solubility of the test item and designed dose, the test item was prepared to suspend in corn oil. Because corn oil was used as vehicle, the route of administration by gavage was used. In the preliminary test, two dose levels were set, include: 2000 and 1000 mg/kg/body weight/day. There were three males and three females in each group. The animals were dosed twice with an interval of 24 hours. The dose volume of 0.2ml/10g bw by gavage. After the second administration, all the animals continued to be observed one day. The results indicated that all animals had no obvious toxic symptoms or were death during the administration of the test item.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
Sampling of peripheral blood was carried out on all animals (7 per dose group)
DETAILS OF SLIDE PREPARATION:
All animals were sacrificed by cervical dislocation nearly 20 hours after the second administration. Bone marrow from sternum was harvested and mixed with a drop of fetal calf serum on a side of a slide. Then the slides were smeared. After air-dried, the slides were fixed in methanol for nearly 10 minutes, and stained with Giemsa’s solution for nearly 30 minutes, flushed and air dried.
METHOD OF ANALYSIS:
The slides were analysed by the manual method using microscopy. All slides were coded randomly so the manual scorer was unaware of the treatment condition. 2000 polychromatic erythrocytes (PCE) were scored per animal for the number of micronucleated polychromatic erythrocytes (MNPCE) and the incidence of micronuclei was shown in permillage. At the same time, the PCE in 200 red blood cells (RBC) were scored and the ratio between PCE and RBC was calculated for each animal.
Observed under immersion objective, both PCE and NCE (normochromatic erythrocytes) are anucleate cells. After Giemsa staining, PCE shows bice and NCE shows light jacinth.
Identification of micronuclei:
Circle is the main form, and oval, ring, hemicycle is found occasionally. Outline of micronuclei is clear and flat. The staining of Micronuclei should be same as the nucleus of an adjacent nucleated cell.
Usually, the upper limit is half of a diameter of an erythrocyte. PCE with two or more micronuclei is counted as one MNPCE. - Evaluation criteria:
- If the incidences of MNPCE in the treated groups show statistically significant increase (P<0.01) compared to the values of the NG and the increase is dose-related or very clear in one dose level, the results are deemed as positive.
The result is evaluated as negative if none of the above criteria is met.
Where small significant increase in the incidences of MNPCE in the treated groups occurs, additional cells may be scored and the biological relevance of the result will be considered. Results of this type will be reported as equivocal if the results maintain unclear. - Statistics:
- Before each administration and sampling, the mean and standard deviation of the body weight in each group was calculated, and plotted graphically respectively; the ratio between PCE and RBC of each animal was calculated, and the mean and standard deviation of the ratios in each group were calculated at the same time (the ratio in the treated groups should not be less than 20% of NG (control). The incidence of MNPCE of each animal was calculated, and the mean and standard deviation in each group were calculated at the same time, then the data were evaluated with two tailed t-test method in Excel to observe if there were statistical significant differences in the treated groups and CP group (positive control) as compared to the value of NG.
Results and discussion
Test results
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 2000 mg/kg bw and 1000 mg/kg bw
- Clinical signs of toxicity in test animals: none observed
- Evidence of cytotoxicity in tissue analyzed: no tissue analyzed
- Rationale for exposure: 2000 mg/kg was chosen as MTD
RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei (for Micronucleus assay): No biologically relevant increase of micronuclei was found, nor were any significant differences between the negative control groups, dose groups and the historical control data found.
- Ratio of PCE/NCE (for Micronucleus assay): No significant difference between the negative control groups, dose groups and the historical control data found.
- Appropriateness of dose levels and route: Both, MTD and oral administration, were appropriate to investigate the genotoxic potential of the test item. The positive control groups showed a significantly increased micronucleus frequency.
- Statistical evaluation: No statistically significant differences between the negative control groups and the dose group were found.
Any other information on results incl. tables
Table 1: Statistics results of microscopic analysis
Group (mg/kg) | Animal number | Number of PCE | MNPCE/PCE (‰) Mean±SD |
P value | PCE/RBC Mean±SD |
0 | 7 | 14000 | 2.3±0.6 | - | 0.55±0.03 |
500 | 7 | 14000 | 2.2±0.6 | > 0.05 | 0.59#±0.07 |
1000 | 7 | 14000 | 2.3±0.7 | > 0.05 | 0.58#±0.04 |
2000 | 7 | 14000 | 1.8±0.9 | > 0.05 | 0.54#±0.08 |
CP | 7 | 14000 | 25.9±3.8 | <0.01* | 0.47#±0.04 |
Note: * statistically significant difference compared to negative control (P<0.01);
# the ratio was more than 20 percent of the ratio in the negative control group.
During the test, the change of animal body weights was determined, there was no obvious decrease as compared with the concurrent NG during the administration.
The clinical observation results showed that all animals had no toxic symptom and death.
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of this study, the results were negative, so the study suggested that 1, 2, 4-Benzenetricarboxylic acid, mixed dodecyl and octyl triesters did not induce an increase of the incidence of micronucleated PCE in mice.
- Executive summary:
This study was conducted to detect the possibility that 1,2,4-Benzenetricarboxylic acid, mixed dodecyl and octyl triesters could induce the increase of the incidence of micronucleated polychromatic erythrocytes (PCE) in mice, in order to provide genotoxicity related data for the test item according to OECD 474. This study was conducted in ICR mice. All animals were SPF grade. According to the related information about the test item and the results of the preliminary test, in the micronucleus test, the animals were treated at 2000, 1000 and 500mg/kg. Negative control group (NG, corn oil) and positive control (Cyclophosphamide, CP, 50mg/kg) group were performed at the same time with the same method. All animals were randomly grouped based on body weight with 7 male animals in each group. Mice were administered the test item orally by gavage twice, with a 24 hours interval between doses. All animals were sacrificed by cervical dislocation nearly 20 hours after the last administration. Bone marrow from sternum was harvested. Bone marrow smear was prepared and analysed with microscope. The data were evaluated with t-test (two-tail) in Excel.
During the administration, no obvious decrease in the body weights of the mice was found in all designed dose groups as compared with the NG. No animal exhibited obvious toxic symptoms and death during the administration.
The frequencies of micronucleated PCE were 2.3±0.6‰ in the negative control group, 2.2±0.6‰ in the 500mg/kg group, 2.3±0.7‰ in the1000 mg/kg group, 1.8±0.9‰ in the 2000mg/kg group and25.9±3.8‰ in the CP group. The results of t-test indicated that statistically no significant difference (P>0.05) in the incidence of micronucleated PCE was found in the treated groups as compared with NG. At the same time, a statistically significant difference (P<0.01) in the incidence of micronucleated PCE was found in the CP group as compared with NG. Furthermore, the PCE/RBC ratios in all treated groups and positive control group were more than twenty percent of the ratio in NG.
Under the conditions of this study, the results were negative, so the study suggested that 1, 2, 4-Benzenetricarboxylic acid, mixed dodecyl and octyl triesters did not induce an increase of the incidence of micronucleated PCE in mice.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.